Navalign LLC’s Delcath Systems DCTH Stock Holding History

Navalign LLC’s Portfolio DCTH Stock Details DCTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-337	Closed	-$3.4K	–	206
2025 Q4	$3.4K	Buy	+337	New	+$3.35K	﹤0.01%	400

Other funds holding DCTH

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PWAC

Private Wealth Advisors (California) Fresno, California $391M AUM 26.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Navalign LLC's DCTH Position: Q1 2026 in Review

Navalign LLC sold out of Delcath Systems (DCTH) in Q1 2026, closing a stake of 337 shares — an estimated $3.4K sold.

Navalign LLC first reported a position in DCTH in Q4 2025 and held it in 1 quarter. The position peaked at $3.4K in Q4 2025. 121 funds tracked by Wall St. Rank hold DCTH as of Q1 2026.

Navalign LLC reported no remaining Delcath Systems position as of Q1 2026 after selling out during the quarter.
Navalign LLC sold 337 Delcath Systems shares in Q1 2026, an estimated $3.4K.
Navalign LLC first reported a position in Delcath Systems in Q4 2025 and held it in 1 quarter.
Navalign LLC's Delcath Systems position peaked at $3.4K in Q4 2025.
121 funds tracked by Wall St. Rank held Delcath Systems as of Q1 2026.

Based on Navalign LLC's 13F filing for Q1 2026, filed 29 Apr 2026.